Exondys 51 (Sarepta Therapeutics, Inc.)
Welcome to the PulseAid listing for the Exondys 51 drug offered from Sarepta Therapeutics, Inc.. This Antisense Oligonucleotide [EPC],Oligonucleotides, Antisense [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sarepta Therapeutics, Inc. |
| NON-PROPRIETARY NAME: | eteplirsen |
| SUBSTANCE NAME: | ETEPLIRSEN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antisense Oligonucleotide [EPC],Oligonucleotides, Antisense [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-09-19 |
| END MARKETING DATE: | 0000-00-00 |
Exondys 51 HUMAN PRESCRIPTION DRUG Details:
| Item Description | Exondys 51 from Sarepta Therapeutics, Inc. |
| LABELER NAME: | Sarepta Therapeutics, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/mL) |
| START MARKETING DATE: | 2016-09-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 60923-284_75cfb2f8-b0bc-4397-bc29-7366026603b5 |
| PRODUCT NDC: | 60923-284 |
| APPLICATION NUMBER: | NDA206488 |
Other ETEPLIRSEN Pharmaceutical Manufacturers / Labelers:
